CFM
NUVB icon

Cornerstone Financial Management’s Nuvation Bio NUVB Stock Holding History

Cornerstone Financial Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06K Hold
186
– – ﹤0.01% 1085
2026
Q1 		$798 Hold
186
– – ﹤0.01% 1037
2025
Q4 		$1.67K Buy
+186
New +$1.15K ﹤0.01% 748

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Cornerstone Financial Management's NUVB Position: Q2 2026 in Review

Cornerstone Financial Management held its Nuvation Bio (NUVB) position steady in Q2 2026 at 186 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #1085.

Cornerstone Financial Management first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.67K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Cornerstone Financial Management held 186 shares of Nuvation Bio worth $1.06K as of Q2 2026.
  • Cornerstone Financial Management left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #1085 holding.
  • Cornerstone Financial Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • Cornerstone Financial Management's Nuvation Bio position peaked at $1.67K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.